The term risk sharing is sometimes tossed around when, technically, there's little or no financial risk involved. One such deal made a big splash in April when Merck & Co. and Cigna announced a discount agreement for sitagliptin (Januvia) and the sitagliptin phosphate/ metformin hydrochloride combination (Janumet), Merck's new oral medications for type 2 diabetes.
展开▼
